Sernova Corp. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. It focuses on its proprietary Cell Pouch, a bio-hybrid organ system which is designed to enhance the delivery of cell therapy to better replicate natural body functions. The company was founded on August 19, 1998 and is headquartered in London, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company